More on CNTB
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.46 |
|
|||
| Open | $2.47 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $2.58 | ||||
| Day Low | $2.46 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 99,797 | ||||
- Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced Therapies Rises | DelveInsight
- Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference
- Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Form SCHEDULE 13G/A Connect Biopharma Holdin Filed by: BioFortune Inc
- Form SCHEDULE 13G/A Connect Biopharma Holdin Filed by: Wei Zheng
- Form SCHEDULE 13G Connect Biopharma Holdin Filed by: Ikarian Capital, LLC
- Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight
- Connect Biopharma reports new mechanism data for rademikibart drug
- Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
- Form 8-K Connect Biopharma Holdin For: Dec 17
Entities mentioned with CNTB
- FDA | View Related Stories »
- Earnings | View Related Stories »
- IPO | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Jefferies & Co | View Related Stories »
- Show More...
